Medicines
General information about medicines, as well as advice on safety information, medicines and pregnancy, and medicine shortages.
Loading...
Medicines pages
-
-
PageSearch for medicines allowed to be supplied in Australia, medicine ingredients and safety information.
-
SectionFind out how to get a medicine or medical device into the ARTG so you can legally sell it in Australia.
More information
- Medicines
- How we regulate medicines
- Medicines and TGA classifications
- Registered medicines
- Australia's medicine labels are becoming clearer
- Tamper-evident packaging
- PI/CMI search facility
- Medicines Repurposing Program - Eligibility criteria and prioritisation considerations
Dispose of unwanted medicines
Health professionals
University student education materials
Latest alerts
-
Safety alertsPossible risk of learning, communication and behaviour problems in children born to men taking this medicine.
-
Safety alertsMore prominent warnings are being added to the Product Information and Consumer Medicine Information for all oral and injectable (systemic) fluoroquinolones to strengthen existing warnings about serious side effects.
-
Safety alertsExtra safety information is being added to all montelukast products to highlight the existing warnings about serious behaviour and mood-related changes
Latest articles
-
Access strategic plan: Updated for 2025-2028
NewsThe updated plan emphasises solidifying our collaborative processes, aligning expectations with industry, and improving our communication strategies. -
Potential risk of neurodevelopmental disorders in children born to men taking sodium valproate
Safety updatesThere may be an increased risk of neurodevelopmental disorders in children born to men who have taken sodium valproate in the 3 months before conception. -
More prominent warnings about serious side effects for fluoroquinolone antibiotics
Safety updatesMore prominent warnings are being added to the product information (PI) and consumer medicine information (CMI) for all oral and injectable (systemic) fluoroquinolones to strengthen existing warnings about serious side effects
Latest publications
-
Scheduling decisions (interim)Interim decisions on proposed amendments to the Poisons Standard closing 4 April 2025
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting Statement 49 for meeting held 2 October 2024
Latest consultations
-
Closed onConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Chemicals Scheduling (ACCS) and joint meeting of the Advisory Committee on Medicines Scheduling (ACMS) and ACCS.
-
Closed onConsultationWe are seeking feedback on whether 19 international scientific guidelines should be adopted.
-
Closed onConsultationWe are seeking feedback on proposed improvements to TGA’s regulatory framework for medicine shortages and discontinuations in Australia.